Tenax Therapeutics Inc (TENX)

Currency in USD
14.0100
-0.7700(-5.21%)
Closed·
14.2500+0.2400(+1.71%)
·
TENX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.970014.9200
52 wk Range
4.630018.3800
Key Statistics
Prev. Close
14.78
Open
14.61
Day's Range
13.97-14.92
52 wk Range
4.63-18.38
Volume
614.88K
Average Vol. (3m)
347.48K
1-Year Change
157.0642%
Book Value / Share
2.39
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TENX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.5714
Upside
+111.07%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Tenax Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.

Compare TENX to Peers and Sector

Metrics to compare
TENX
Peers
Sector
Relationship
P/E Ratio
−13.4x−1.8x−0.5x
PEG Ratio
0.86−0.090.00
Price / Book
7.3x1.9x2.6x
Price / LTM Sales
-10.3x3.2x
Upside (Analyst Target)
103.0%168.5%45.7%
Fair Value Upside
Unlock5.2%4.8%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.5714
(+111.07% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Cantor Fitzgerald
Buy35.00+149.82%-New CoverageMar 17, 2026
William Blair
Buy---MaintainMar 10, 2026
Leerink Partners
Buy26.00+85.58%-MaintainMar 10, 2026
Guggenheim
Buy25.00+78.44%14.00MaintainDec 17, 2025
Piper Sandler
Buy20.00+42.76%-New CoverageSep 08, 2025

Earnings

Latest Release
Mar 10, 2026
EPS / Forecast
-0.38 / -0.23
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TENX Income Statement

People Also Watch

3.30
BATL
-1.49%
5.3100
ARTL
-1.85%
7.78
IBRX
+2.37%
62.930
AXTI
-6.49%
3.0700
HURA
-2.54%

FAQ

What Is the Tenax Therapeutics (TENX) Stock Price Today?

The Tenax Therapeutics stock price today is 14.0100 USD.

What Stock Exchange Does Tenax Therapeutics Trade On?

Tenax Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Tenax Therapeutics?

The stock symbol for Tenax Therapeutics is "TENX."

What Is the Tenax Therapeutics Market Cap?

As of today, Tenax Therapeutics market cap is 707.7300M USD.

What Is Tenax Therapeutics's Earnings Per Share (TTM)?

The Tenax Therapeutics EPS (TTM) is -1.3412.

From a Technical Analysis Perspective, Is TENX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Tenax Therapeutics Stock Split?

Tenax Therapeutics has split 5 times.

How Many Employees Does Tenax Therapeutics Have?

Tenax Therapeutics has 15 employees.

What is the current trading status of Tenax Therapeutics (TENX)?

As of Apr 16, 2026, Tenax Therapeutics (TENX) is trading at a price of 14.0100 USD, with a previous close of 14.7800 USD. The stock has fluctuated within a day range of 13.9700 USD to 14.9200 USD, while its 52-week range spans from 4.6300 USD to 18.3800 USD.

What Is Tenax Therapeutics (TENX) Price Target According to Analysts?

The average 12-month price target for Tenax Therapeutics is 29.5714 USD, with a high estimate of 35 USD and a low estimate of 20 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +111.07% Upside potential.

What Is the TENX Premarket Price?

TENX's last pre-market stock price is 14.2600 USD. The pre-market share volume is 50.0000, and the stock has decreased by -0.5200, or -3.5200%.

What Is the TENX After Hours Price?

TENX's last after hours stock price is 14.2500 USD, the stock has decreased by 0.2400, or 1.7100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.